Properties of the Nerve Growth Factor Receptor. Relationship Between Receptor Structure and Affinity
Overview
Authors
Affiliations
Microsomal membranes from A875 human melanoma cells contain nerve growth factor receptors (NGF-receptors) which appear to belong to a single class with homogeneous binding properties, as determined by Scatchard plots. NGF-receptors in these membrane preparations are also uniformly highly sensitive to tryptic proteolysis, and 125I-NGF bound to NGF-receptor in these membranes is rapidly dissociated in the presence of a high concentration of unlabeled NGF. However, analysis of 125I-NGF dissociation kinetics indicated that two classes of NGF-receptor were present in these membranes. Thus, NGF-receptors can express either high or low affinity trypsin-sensitive states in addition to the high affinity trypsin resistant NGF-receptor state described previously (Buxser, S. E., Kelleher, D. J., Watson, L., Puma, P., and Johnson, G. L. (1983) J. Biol. Chem. 258, 3741-3749). The high affinity trypsin-sensitive and low affinity trypsin-sensitive states correlate with 200- and 90-kDa 125I-NGF X NGF-receptor complexes observed in photoaffinity cross-linking experiments. The absence of differences in peptide maps generated from the two sizes of NGF-receptor proteins together with structural and binding data strongly indicates that the 200-kDa NGF-receptor protein is a complex, probably a dimer, consisting of two 80-kDa NGF-receptor proteins associated with a single beta-NGF dimeric molecule. A model is proposed which relates structural states of NGF-receptors with specific receptor binding properties. The model provides an alternative explanation for binding phenomena previously attributed to negative cooperativity.
Elucidating the Preadipocyte and Its Role in Adipocyte Formation: a Comprehensive Review.
Sarantopoulos C, Banyard D, Ziegler M, Sun B, Shaterian A, Widgerow A Stem Cell Rev Rep. 2017; 14(1):27-42.
PMID: 29027120 DOI: 10.1007/s12015-017-9774-9.
Bradshaw R, Mobley W, Rush R Int J Mol Sci. 2017; 18(6).
PMID: 28587118 PMC: 5485967. DOI: 10.3390/ijms18061143.
Walmsley G, Atashroo D, Maan Z, Hu M, Zielins E, Tsai J Tissue Eng Part A. 2015; 21(15-16):2281-91.
PMID: 26020286 PMC: 4529076. DOI: 10.1089/ten.TEA.2015.0039.
Tiesman J, Rizzino A Cytotechnology. 2012; 2(4):333-50.
PMID: 22358873 DOI: 10.1007/BF00364997.
Paul A, GRANT E, Habib F Br J Cancer. 1996; 74(12):1990-6.
PMID: 8980402 PMC: 2074798. DOI: 10.1038/bjc.1996.665.